Outcomes of Second-Line Treatment By Dasatinib in Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia Patients with and without Comorbidities

Details

Language :

English

ISSN :

00064971 and 15280020

Volume :

126

Issue :

23

Database :

Supplemental Index

Journal :

Blood

Publication Type :

Periodical

Accession number :

ejs56869006

Full Text :

https://doi.org/10.1182/blood.V126.23.5147.5147